Revenue Performance - Quell revenue increased by 50% to $184,000 in Q3 2024 from $123,000 in Q3 2023[3] - DPNCheck revenue of $404,000 in Q3 2024 declined by $568,000 or 58% from Q3 2023[4] - Total revenue in Q3 2024 was $0.6 million, down by $0.6 million or 51% from Q3 2023[5] - Revenue for the nine months ended September 30, 2024, was $2.5 million, a decline of $2.1 million or 47% from the same period in 2023[6] Profitability - Gross profit in Q3 2024 was $0.3 million, down by $0.5 million due to DPNCheck revenue decline and lower production volume[5] - Net loss in Q3 2024 was $1.5 million, or ($0.75) per share, compared to a net loss of $1.8 million, or ($1.66) per share, in Q3 2023[5] - Net loss for the nine months ended September 30, 2024, was $6.0 million, or ($3.10) per share, compared to a net loss of $4.9 million, or ($4.86) per share, in the prior year[6] Expenses - Operating expenses in Q3 2024 were $2.1 million, reduced by $0.7 million or 25% from the prior year[5] Financial Position - As of September 30, 2024, cash, cash equivalents, and securities totaled $14.8 million[6] Strategic Initiatives - The company is actively pursuing a review of strategic alternatives to enhance shareholder value[1]
NeuroMetrix(NURO) - 2024 Q3 - Quarterly Results